• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性多囊肾病中肾体积与肾功能的关系。

The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.

机构信息

Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

出版信息

Clin Exp Nephrol. 2011 Aug;15(4):539-45. doi: 10.1007/s10157-011-0428-y. Epub 2011 Mar 24.

DOI:10.1007/s10157-011-0428-y
PMID:21431900
Abstract

BACKGROUND

In patients with autosomal dominant polycystic kidney disease (ADPKD), renal cysts grow exponentially. Since remaining renal parenchyma has a capacity to compensate for the loss of glomerular filtration, the glomerular filtration rate (GFR) may be sustained until the disease progresses. The purpose of this study was to determine if renal volumetric indices and clinical parameters are associated with renal function in Japanese patients with ADPKD.

METHODS

In 73 ADPKD patients (28 men, 45 women), the associations of mean systolic blood pressure, mean diastolic blood pressure, estimated GFR (eGFR), the amount of proteinuria and albuminuria, body mass index (BMI), brachial-ankle pulse wave velocity (baPWV), ankle-brachial index, and total kidney volume (TKV) were retrospectively analyzed.

RESULTS

Multivariate linear regression analysis showed that eGFR was significantly and independently inversely correlated with patients' age and BMI. The median change in eGFR per year (ΔeGFR/y) was -2.8 ml/min/1.73 m(2)/year. Multiple linear regression analysis showed that ΔeGFR/y was significantly and independently inversely correlated with the change in TKV per year (ΔTKV/y). Multiple linear regression analysis showed that ΔTKV/y was significantly related to initial TKV and the change in albuminuria per year.

CONCLUSIONS

This study demonstrated a significant relationship between the change in renal function and the change in renal volume in Japanese ADPKD patients without renal insufficiency. It is possible that the volume measurements can be used as useful markers for disease progression in Japanese ADPKD patients.

摘要

背景

常染色体显性多囊肾病(ADPKD)患者的肾囊肿呈指数级生长。由于剩余的肾实质有能力代偿肾小球滤过率的损失,因此肾小球滤过率(GFR)可能在疾病进展之前保持不变。本研究旨在确定日本 ADPKD 患者的肾脏体积指数和临床参数是否与肾功能相关。

方法

在 73 名 ADPKD 患者(28 名男性,45 名女性)中,回顾性分析了平均收缩压、平均舒张压、估算肾小球滤过率(eGFR)、蛋白尿和白蛋白尿量、体重指数(BMI)、肱踝脉搏波速度(baPWV)、踝臂指数和总肾体积(TKV)与肾功能的关系。

结果

多元线性回归分析显示,eGFR 与患者年龄和 BMI 呈显著负相关。eGFR 每年的中位数变化(ΔeGFR/y)为-2.8ml/min/1.73m(2)/year。多元线性回归分析显示,ΔeGFR/y 与 TKV 每年的变化(ΔTKV/y)呈显著负相关。多元线性回归分析显示,ΔTKV/y 与初始 TKV 和每年白蛋白尿的变化显著相关。

结论

本研究表明,肾功能的变化与日本 ADPKD 患者肾功能正常患者的肾体积变化之间存在显著关系。体积测量值可能可作为日本 ADPKD 患者疾病进展的有用标志物。

相似文献

1
The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾体积与肾功能的关系。
Clin Exp Nephrol. 2011 Aug;15(4):539-45. doi: 10.1007/s10157-011-0428-y. Epub 2011 Mar 24.
2
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).常染色体显性多囊肾病中肾功能下降和肾体积增长的预测因素:一项前瞻性队列研究(日本多囊肾病登记处:J-PKD)
Clin Exp Nephrol. 2021 Sep;25(9):970-980. doi: 10.1007/s10157-021-02068-x. Epub 2021 Apr 29.
3
The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.亚洲多囊肾病患者肾脏体积与肾小球滤过率测定值的相关性:一项前瞻性队列研究。
BMC Nephrol. 2021 May 15;22(1):178. doi: 10.1186/s12882-021-02392-0.
4
Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functions.与广泛肾功能的常染色体显性多囊肾病患者使用托伐普坦治疗 1 年疗效相关的临床特征。
J Med Invest. 2020;67(3.4):315-320. doi: 10.2152/jmi.67.315.
5
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾血流的磁共振测量与疾病进展
Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. doi: 10.2215/CJN.00910306. Epub 2006 Nov 2.
6
Kidney volume and function in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的肾脏体积与功能
Clin Exp Nephrol. 2014 Feb;18(1):157-65. doi: 10.1007/s10157-013-0834-4. Epub 2013 Jul 18.
7
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.托伐普坦治疗常染色体显性遗传多囊肾病:三年经验。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2499-507. doi: 10.2215/CJN.03530411. Epub 2011 Sep 8.
8
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.托伐普坦对不同肾功能水平常染色体显性多囊肾病个体的短期疗效。
Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15.
9
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.超重和肥胖是常染色体显性遗传多囊肾病早期进展的预测因素。
J Am Soc Nephrol. 2018 Feb;29(2):571-578. doi: 10.1681/ASN.2017070819. Epub 2017 Nov 8.
10
The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.成人常染色体显性多囊肾病患者血清血管生成生长因子与肾脏结构和功能的关系
Int Urol Nephrol. 2018 Jul;50(7):1293-1300. doi: 10.1007/s11255-018-1866-1. Epub 2018 Apr 13.

引用本文的文献

1
Reduction of polycystic kidney and liver volumes in a patient with tolvaptan-resistant autosomal dominant polycystic kidney disease and acromegaly during lanreotide therapy.在接受兰瑞肽治疗期间,一名患有托伐普坦耐药性常染色体显性多囊肾病和肢端肥大症的患者多囊肾和肝体积减小。
CEN Case Rep. 2025 Jun 27. doi: 10.1007/s13730-025-01013-1.
2
Fully automated kidney image biomarker prediction in ultrasound scans using Fast-Unet+.基于 Fast-Unet+的全自动超声肾图像生物标志物预测
Sci Rep. 2024 Feb 27;14(1):4782. doi: 10.1038/s41598-024-55106-5.
3
Calculation of Kidney Volumes with Magnetic Resonance in Patients with Autosomal Dominant Polycystic Kidney Disease: Comparison between Methods.

本文引用的文献

1
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.长作用生长抑素治疗常染色体显性遗传多囊肾病和多囊肝病的随机临床试验。
J Am Soc Nephrol. 2010 Jun;21(6):1052-61. doi: 10.1681/ASN.2009121291. Epub 2010 Apr 29.
2
Imaging for the prognosis of autosomal dominant polycystic kidney disease.多囊肾病的影像学预后评估。
Nat Rev Nephrol. 2010 Feb;6(2):96-106. doi: 10.1038/nrneph.2009.214.
3
Prospective change in renal volume and function in children with ADPKD.常染色体显性多囊肾病患儿肾脏体积和功能的前瞻性变化
常染色体显性多囊肾病患者肾脏体积的磁共振测量:方法比较
Diagnostics (Basel). 2023 Nov 30;13(23):3573. doi: 10.3390/diagnostics13233573.
4
The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.亚洲多囊肾病患者肾脏体积与肾小球滤过率测定值的相关性:一项前瞻性队列研究。
BMC Nephrol. 2021 May 15;22(1):178. doi: 10.1186/s12882-021-02392-0.
5
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).常染色体显性多囊肾病中肾功能下降和肾体积增长的预测因素:一项前瞻性队列研究(日本多囊肾病登记处:J-PKD)
Clin Exp Nephrol. 2021 Sep;25(9):970-980. doi: 10.1007/s10157-021-02068-x. Epub 2021 Apr 29.
6
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.常染色体显性遗传多囊肾病患者肾功能的长期变化轨迹。
Kidney Int. 2019 May;95(5):1253-1261. doi: 10.1016/j.kint.2018.12.023. Epub 2019 Mar 4.
7
Should kidney volume be used as an indicator of surgical occasion for patients with autosomal dominant polycystic kidney disease?对于常染色体显性遗传性多囊肾病患者,肾脏体积是否应作为手术时机的一个指标?
Medicine (Baltimore). 2018 Jul;97(27):e11445. doi: 10.1097/MD.0000000000011445.
8
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.在常染色体显性多囊肾病中,基线总肾体积和肾脏生长速度与慢性肾脏病进展相关。
Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.
9
Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中新型半自动肾脏体积测量方法
Clin Exp Nephrol. 2018 Jun;22(3):583-590. doi: 10.1007/s10157-017-1486-6. Epub 2017 Nov 3.
10
The importance of total kidney volume in evaluating progression of polycystic kidney disease.总肾体积在评估多囊肾病进展中的重要性。
Nat Rev Nephrol. 2016 Nov;12(11):667-677. doi: 10.1038/nrneph.2016.135. Epub 2016 Oct 3.
Clin J Am Soc Nephrol. 2009 Apr;4(4):820-9. doi: 10.2215/CJN.02810608.
4
Revised equations for estimated GFR from serum creatinine in Japan.日本基于血清肌酐估算肾小球滤过率的修订方程。
Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1.
5
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.常染色体显性遗传性多囊肾病患者的肾体积增大在6个月内即可被检测到。
Kidney Int. 2009 Jan;75(2):235-41. doi: 10.1038/ki.2008.558. Epub 2008 Oct 29.
6
Clinical practice. Autosomal dominant polycystic kidney disease.临床实践。常染色体显性遗传性多囊肾病
N Engl J Med. 2008 Oct 2;359(14):1477-85. doi: 10.1056/NEJMcp0804458.
7
Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease.多囊肾病中雷帕霉素的哺乳动物靶点与半胱天冬酶抑制剂
Clin J Am Soc Nephrol. 2008 Jul;3(4):1219-26. doi: 10.2215/CJN.05611207.
8
Role of vasopressin antagonists.血管加压素拮抗剂的作用。
Clin J Am Soc Nephrol. 2008 Jul;3(4):1212-8. doi: 10.2215/CJN.05281107. Epub 2008 Apr 23.
9
Sirolimus reduces polycystic liver volume in ADPKD patients.西罗莫司可减小常染色体显性多囊肾病患者的多囊肝体积。
J Am Soc Nephrol. 2008 Mar;19(3):631-8. doi: 10.1681/ASN.2007050626. Epub 2008 Jan 16.
10
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.常染色体显性多囊肾病中的囊肿体积进展:决定临床结局的主要因素
Clin J Am Soc Nephrol. 2006 Jan;1(1):148-57. doi: 10.2215/CJN.00330705. Epub 2005 Oct 19.